Orion Corporation, Orion Pharma

🇫🇮Finland

Country: 🇫🇮Finland

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis

Phase 2

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Drug: ODM-109
Drug: Placebo for ODM-109

First Posted Date: 2015-07-01

Last Posted Date: 2017-11-28

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 66

Registration Number: NCT02487407

Locations: 🇳🇱
University Medical Centre Utrecht, Utrecht, Netherlands
🇩🇪
Charite Universitatsmedizin Berlin, Berlin, Germany
🇩🇪
Medical School Hannover, Hannover, Germany

and more 8 locations

Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease

Phase 2

Completed

Conditions: Alzheimer's Disease

Interventions: Drug: ORM-12741
Drug: Placebo

First Posted Date: 2015-06-15

Last Posted Date: 2018-02-15

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 308

Registration Number: NCT02471196

Locations: 🇫🇮
Clinical Research Services Turku - CRST Oy, Turku, Finland

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of ODM-108: in Healthy Male Volunteers

Phase 1

Terminated

Conditions: Healthy

Interventions: Drug: Placebo Part I
Drug: ODM-108-Part II
Drug: ODM-108 Part I
Drug: Placebo Part II
Drug: ODM-108 Part III
Drug: Midazolam

First Posted Date: 2015-05-04

Last Posted Date: 2017-07-02

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 85

Registration Number: NCT02432664

Locations: 🇳🇱
PRA Health Sciences, Zuidlaren, Netherlands

Mass Balance, Pharmacokinetics, Biotransformation and Bioavailability Study of ODM-201 in Healthy Male Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: ODM-201 300 mg tablet
Drug: 300 mg 14C-ODM-201 oral solution
Drug: intravenous14C-ODM-201

First Posted Date: 2015-04-16

Last Posted Date: 2015-06-23

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 12

Registration Number: NCT02418650

Locations: 🇬🇧
Quotient Clinical, Nottingham, United Kingdom

Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteer Study

Interventions: Drug: ODM-106
Drug: Placebo

First Posted Date: 2015-03-20

Last Posted Date: 2016-12-23

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 16

Registration Number: NCT02393950

Locations: 🇩🇪
Parexel International GmbH, Berlin, Germany

Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: ODM-204
Drug: Prednisone

First Posted Date: 2015-01-22

Last Posted Date: 2019-12-19

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 23

Registration Number: NCT02344017

Locations: 🇫🇮
Helsinki University Central Hospital, Helsinki, Finland
🇱🇻
P. Stradins Clinical University Hospital, Riga, Latvia
🇫🇷
Institut Gustave Roussy, Villejuif, France

and more 1 locations

Pharmacokinetic Study of Single Doses of ORM-12741

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: ORM-12741 MR A
Drug: ORM-12741 IR
Drug: ORM-12741 MR B

First Posted Date: 2014-12-18

Last Posted Date: 2015-05-06

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 23

Registration Number: NCT02319057

Locations: 🇫🇮
Clinical Research Services Turku, CRST, Turku, Finland

Pharmacokinetic Study in Healthy Males

Phase 1

Completed

Conditions: Parkinson's Disease

Interventions: Drug: levodopa, carbidopa, ODM-104

First Posted Date: 2014-12-09

Last Posted Date: 2015-02-18

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 20

Registration Number: NCT02312232

Locations: 🇫🇮
CRST, Turku, Finland

To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product

Phase 3

Completed

Conditions: Asthma

Interventions: Drug: Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh
Drug: Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh
Drug: Symbicort Turbuhaler 320/9 ug/inhalation 4 inh
Drug: Symbicort Turbuhaler 320/9 ug/inhalation 1inh
Drug: Placebo Symbicort Turbuhaler 320/9 ug/inhalation 4 inh
Drug: Placebo Symbicort Turbuhaler 320/9 ug/inhalation 1 inh
Drug: Placebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh
Drug: Placebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh